サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446536

臨床データ分析ソリューション市場規模、シェア、動向分析レポート：展開別、用途別、地域別、セグメント予測、2024年～2030年

Clinical Data Analytics Solutions Market Size, Share & Trends Analysis Report By Deployment (Cloud-based, On-premise), By Application (Clinical Decision Support, Clinical Trials, Regulatory Compliance), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
臨床データ分析ソリューション市場規模、シェア、動向分析レポート：展開別、用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年02月20日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床データ分析ソリューション市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床データ分析ソリューション市場規模は、2024年から2030年にかけて顕著なCAGR 6.8%で拡大し、2030年には75億米ドルに達すると予測されています。

市場成長を促進する主な要因には、ヘルスケア組織における先進技術へのニーズの高まり、集団健康管理への注目の高まり、臨床試験数の増加などがあります。

医療施設や臨床研究において、AIを活用した臨床データ分析ソリューションの採用が増加していることは、市場成長の主要な促進要因です。AIの自動化は、調査、検査結果、患者記録などさまざまなソースからのデータ収集と分析に不可欠です。AIアルゴリズムは迅速なデータ分析を可能にし、複数の施設における臨床業務の効率を高める貴重な洞察をもたらします。例えば、メディデータは2022年10月、キメラ抗原受容体T細胞療法を受ける患者における重症サイトカイン放出症候群の発症を予測する検査マーカーを特定するため、ビッグデータモデリング技術を活用しました。

COVID-19の大流行によりヘルスケア部門は大きく成長し、患者データの急増を管理するためのデジタルソリューションと高度な分析ツールに対する需要の高まりがこれに拍車をかけました。パンデミック中に生成された膨大な臨床データの効果的な取り扱いは、分析プラットフォームによって可能になり、調査やヘルスケア専門家がより良い結果を得たり、動向を予測したり、疾病伝播パターンについてより深い洞察を得ることができるようになった。

同市場の主要企業は、市場での地位を強化するため、パートナーシップ、提携、新製品の発売、買収、事業拡大などの戦略的取り組みを行っています。2023年3月、Syneos HealthとKXは、臨床試験の効率化、市場投入期間の短縮、効果的な患者治療のためのコスト削減を目的とした戦略的パートナーシップを締結しました。この戦略的パートナーシップは、業界初のData Timehouseを通じてAI、ML、データ主導型の予測分析機能を提供することに重点を置いています。さらに、この革新的なデータとAIの管理エンジンは、デジタルトランスフォーメーションによって生成される時間的データを扱うように設計されており、顧客が複雑なヘルスケアに関する意思決定を行えるよう支援します。

臨床データ分析ソリューション市場レポートハイライト

  • 展開セグメントに基づくと、クラウドベースセグメントが2023年に55.58%の最大市場シェアで優位を占め、ユーザーフレンドリーな技術と費用対効果の採用増加により、予測期間中に最も急成長するセグメントと予測されます。
  • 用途別では、臨床試験分野が2023年に最大の市場シェアを占めたが、これは臨床データ分析ソリューションの導入に伴うメリットに対する認識が高まっているためです。
  • 2023年には、北米が臨床データ分析ソリューション業界を支配しました。これは、同地域の先進的なヘルスケアインフラと、政策やイニシアティブを通じた政府の支援によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床データ分析ソリューション市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • 臨床データ分析ソリューション市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 臨床データ分析ソリューション市場：展開推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 展開別の世界の臨床データ分析ソリューション市場の見通し

第5章 臨床データ分析ソリューション市場：用途の推定・動向分析

  • 定義と範囲
  • セグメントダッシュボード
  • 用途別の世界の臨床データ分析ソリューション市場の見通し

第6章 臨床データ分析ソリューション市場：地域推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • 市場規模、予測、量および動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • タイ
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • 主要企業の市場シェア分析、2023年
  • 主要企業の市況分析、2023年
  • 企業プロファイル
    • Optum, Inc.
    • SAS Institute Inc.
    • IQVIA
    • Health Catalyst
    • eClinical Solutions LLC
    • JMP Statistical Discovery LLC.
    • OSP
    • BD
    • Dassault Systems
    • Cognizant
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical data analytics solutions market, by Region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical data analytics solutions market, by deployment 2018 - 2030 (USD Million)
  • Table 4 North America clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical data analytics solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical data analytics solutions market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical data analytics solutions market, by Region, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 13 UK clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 14 Germany clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 15 Germany clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 16 France clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 17 France clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 22 Sweden clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 23 Sweden clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 24 Denmark clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 25 Denmark clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 26 Norway clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 27 Norway clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical data analytics solutions market, by Region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 31 Japan clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 32 Japan clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 33 China clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 34 China clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 35 India clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 36 India clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical data analytics solutions market, by Region, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical data analytics solutions market, by Region, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical data analytics solutions market, by deployment, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical data analytics solutions market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Clinical data analytics solutions market: market outlook
  • Fig. 14 Clinical data analytics solutions market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical data analytics solutions market driver impact
  • Fig. 20 Clinical data analytics solutions market restraint impact
  • Fig. 21 Clinical data analytics solutions market strategic initiatives analysis
  • Fig. 22 Clinical data analytics solutions market: deployment movement analysis
  • Fig. 23 Clinical data analytics solutions market: deployment outlook and key takeaways
  • Fig. 24 Cloud-based market estimates and forecast, 2018 - 2030
  • Fig. 25 On-premise market estimates and forecast, 2018 - 2030
  • Fig. 26 Clinical data analytics solutions market: application movement analysis
  • Fig. 27 Clinical data analytics solutions market: application outlook and key takeaways
  • Fig. 28 Clinical decision support market estimates and forecast, 2018 - 2030
  • Fig. 29 Clinical Trials market estimates and forecast, 2018 - 2030
  • Fig. 30 Regulatory compliance market estimates and forecast, 2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Global clinical data analytics solutions market: Regional movement analysis
  • Fig. 33 Global clinical data analytics solutions market: Regional outlook and key takeaways
  • Fig. 34 Global market shares and leading players
  • Fig. 35 North America market share and leading players
  • Fig. 36 Europe market share and leading players
  • Fig. 37 Asia Pacific market share and leading players
  • Fig. 38 Latin America market share and leading players
  • Fig. 39 Middle East & Africa market share and leading players
  • Fig. 40 North America: SWOT
  • Fig. 41 Europe SWOT
  • Fig. 42 Asia Pacific SWOT
  • Fig. 43 Latin America SWOT
  • Fig. 44 MEA SWOT
  • Fig. 45 North America, by country
  • Fig. 46 North America
  • Fig. 47 North America market estimates and forecast, 2018 - 2030
  • Fig. 48 U.S.
  • Fig. 49 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 50 Canada
  • Fig. 51 Canada market estimates and forecast, 2018 - 2030
  • Fig. 52 Europe
  • Fig. 53 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 54 UK
  • Fig. 55 UK market estimates and forecast, 2018 - 2030
  • Fig. 56 Germany
  • Fig. 57 Germany market estimates and forecast, 2018 - 2030
  • Fig. 58 France
  • Fig. 59 France market estimates and forecast, 2018 - 2030
  • Fig. 60 Italy
  • Fig. 61 Italy market estimates and forecast, 2018 - 2030
  • Fig. 62 Spain
  • Fig. 63 Spain market estimates and forecast, 2018 - 2030
  • Fig. 64 Denmark
  • Fig. 65 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 66 Sweden
  • Fig. 67 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 68 Norway
  • Fig. 69 Norway market estimates and forecast, 2018 - 2030
  • Fig. 70 Asia Pacific
  • Fig. 71 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 72 Japan
  • Fig. 73 Japan market estimates and forecast, 2018 - 2030
  • Fig. 74 China
  • Fig. 75 China market estimates and forecast, 2018 - 2030
  • Fig. 76 India
  • Fig. 77 India market estimates and forecast, 2018 - 2030
  • Fig. 78 Australia
  • Fig. 79 Australia market estimates and forecast, 2018 - 2030
  • Fig. 80 Thailand
  • Fig. 81 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 82 South Korea
  • Fig. 83 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 84 Latin America
  • Fig. 85 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 86 Brazil
  • Fig. 87 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 88 Mexico
  • Fig. 89 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 90 Argentina
  • Fig. 91 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 92 Middle East and Africa
  • Fig. 93 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 94 Saudi Arabia
  • Fig. 95 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 96 South Africa
  • Fig. 97 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 98 UAE
  • Fig. 99 UAE market estimates and forecast, 2018 - 2030
  • Fig. 100 Kuwait
  • Fig. 101 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 102 Participant categorization- clinical data analytics solutions market
  • Fig. 103 Market share of key market players- clinical data analytics solutions market
目次
Product Code: GVR-4-68040-197-1

Clinical Data Analytics Solutions Market Growth & Trends:

The global clinical data analytics solutions market size is anticipated to reach USD 7.5 billion by 2030, expanding at a notable CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Major factors driving the market growth include the increasing need for advanced technologies in healthcare organizations, increasing focus on population health management, and a growing number of clinical trials.

Increasing adoption of AI-powered clinical data analytics solutions in healthcare facilities and clinical research is a key driver of market growth. AI automation is vital in gathering and analyzing data from various sources, such as surveys, lab results, and patient records. AI algorithms enable rapid data analysis, delivering valuable insights that enhance the efficiency of clinical operations at multiple sites. For instance, in October 2022, Medidata utilized a big data modeling technique to identify lab markers that predict the development of severe cytokine release syndrome in patients undergoing chimeric antigen receptor T-cell therapy.

The COVID-19 pandemic led to significant growth in the healthcare sector, fueled by rising demand for digital solutions and advanced analytics tools to manage the surge in patient data. Effectively handling the extensive clinical data generated during the pandemic was made possible through analytics platforms, enabling researchers and healthcare professionals to obtain better outcomes, predict trends, and gain deeper insights into disease transmission patterns.

Key players in the market are engaged in strategic initiatives such as partnerships, collaborations, new product launches, acquisitions, and expansions to strengthen their market position. In March 2023, Syneos Health and KX formed a strategic partnershipwith the goal of enhancing clinical trial efficiency, reducing time to market, and lowering costs for effective patient therapies. This strategic partnership focuses on providing AI, ML, and data-driven predictive analytics capabilities through the industry's first Data Timehouse. Furthermore, this innovative data and AI management engine is designed to handle temporal data generated by digital transformation, helping customers make complex healthcare decisions.

Clinical Data Analytics Solutions Market Report Highlights:

  • Based on deployment, the cloud-based segment dominated with the largest market share of 55.58% in 2023 and is anticipated to be the fastest-growing segment over the forecast period owing to the increasing adoption of user-friendly technology and cost-effectiveness
  • Based on application, the clinical trials segment held the largest market share in 2023, owing to the increasing awareness of the benefits associated with the adoption of clinical data analytics solutions
  • In 2023, North America dominated the clinical data analytics solutions industry. This was attributed to the region's advanced healthcare infrastructure and government support through policies and initiatives

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Deployment
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Deployment outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Data Analytics Solutions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Reimbursement framework
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing need for advanced technologies in healthcare organizations
      • 3.3.1.2. Growing number of clinical trials
      • 3.3.1.3. Increasing focus on population health management
      • 3.3.1.4. Rising prevalence of chronic diseases
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Data privacy and theft issues
      • 3.3.2.2. Lack of skilled professionals
    • 3.3.3. Industry Challenge
  • 3.4. Clinical Data Analytics Solutions Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Clinical Data Analytics Solutions Market: Deployment Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Cloud-based
    • 4.1.2. On-premise
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Data Analytics Solutions Market by Deployment Outlook
    • 4.3.1. Cloud-based
      • 4.3.1.1. Cloud-based market estimates and forecast 2018 to 2030 (USD Million)
    • 4.3.2. On-premise
      • 4.3.2.1. On-premise market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Clinical Data Analytics Solutions Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Clinical Decision Support
    • 5.1.2. Clinical Trials
    • 5.1.3. Regulatory Compliance
    • 5.1.4. Others
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Data Analytics Solutions Market by Application Outlook
    • 5.3.1. Clinical Decision Support
      • 5.3.1.1. Cinical decision support market estimates and forecast 2018 to 2030 (USD Million)
    • 5.3.2. Clinical Trials
      • 5.3.2.1. Clinical trials market estimates and forecast 2018 to 2030 (USD Million)
    • 5.3.3. Regulatory Compliance
      • 5.3.3.1. Regulatory compliance market estimates and forecast 2018 to 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Clinical Data Analytics Solutions Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. Market estimates and forecast, 2018 - 2030
    • 6.5.2. U.S.
      • 6.5.2.1. Market estimates and forecast, 2018 - 2030
    • 6.5.3. Canada
      • 6.5.3.1. Market estimates and forecast, 2018 - 2030
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Market estimates and forecast, 2018 - 2030
    • 6.6.2. Germany
      • 6.6.2.1. Market estimates and forecast, 2018 - 2030
    • 6.6.3. France
      • 6.6.3.1. Market estimates and forecast, 2018 - 2030
    • 6.6.4. Italy
      • 6.6.4.1. Market estimates and forecast, 2018 - 2030
    • 6.6.5. Spain
      • 6.6.5.1. Market estimates and forecast, 2018 - 2030
    • 6.6.6. Sweden
      • 6.6.6.1. Market estimates and forecast, 2018 - 2030
    • 6.6.7. Denmark
      • 6.6.7.1. Market estimates and forecast, 2018 - 2030
    • 6.6.8. Norway
      • 6.6.8.1. Market estimates and forecast, 2018 - 2030
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Market estimates and forecast, 2018 - 2030
    • 6.7.2. China
      • 6.7.2.1. Market estimates and forecast, 2018 - 2030
    • 6.7.3. India
      • 6.7.3.1. Market estimates and forecast, 2018 - 2030
    • 6.7.4. South Korea
      • 6.7.4.1. Market estimates and forecast, 2018 - 2030
    • 6.7.5. Thailand
      • 6.7.5.1. Market estimates and forecast, 2018 - 2030
    • 6.7.6. Australia
      • 6.7.6.1. Market estimates and forecast, 2018 - 2030
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Market estimates and forecast, 2018 - 2030
    • 6.8.2. Mexico
      • 6.8.2.1. Market estimates and forecast, 2018 - 2030
    • 6.8.3. Argentina
      • 6.8.3.1. Market estimates and forecast, 2018 - 2030
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Market estimates and forecast, 2018 - 2030
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Market estimates and forecast, 2018 - 2030
    • 6.9.3. UAE
      • 6.9.3.1. Market estimates and forecast, 2018 - 2030
    • 6.9.4. Kuwait
      • 6.9.4.1. Market estimates and forecast, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key Company Market Share Analysis, 2023
  • 7.4. Key Company Market Position Analysis, 2023
  • 7.5. Company Profiles
    • 7.5.1. Optum, Inc.
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. SAS Institute Inc.
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. IQVIA
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Health Catalyst
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. eClinical Solutions LLC
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. JMP Statistical Discovery LLC.
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. OSP
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. BD
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Dassault Systems
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Cognizant
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product benchmarking
      • 7.5.10.4. Strategic initiatives